首轨生物治疗 TRAX
$47.90 +$2.47 (+5.44%)
休市 · Nov 7, 9:10 am ET · 最新盘后价 $49.00 +2.30%
开盘$45.94
昨收$45.43
当日区间$45.35 – $48.24
成交量590.3K
市值$2.01B
市盈率（TTM）–
股息率–
TRAX 相关新闻
匹配 First Tracks Biotherapeutics 或代码 TRAX 的头条新闻，按最新排序。
- CCORF Initiates First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Announces Target Price $50
- H.C. Wainwright Maintains First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Maintains Target Price $57
- Barclays Maintains First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Maintains Target Price $65
- Wedbush Maintains First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Raises Target Price to $70 正面
- Evercore Initiates First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Announces Target Price $65
- Guggenheim Initiates First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Announces Target Price $100
- Piper Sandler Maintains First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Maintains Target Price $95
- Analysts Offer Insights on NA Companies: Arcturus Therapeutics (ARCT), EquipmentShare.com, Inc. (EQPT) and First Tracks Biotherapeutics Inc (TRAX)
- J.P. Morgan Maintains First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Raises Target Price to $65 正面
- UBS Maintains First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Maintains Target Price $65
- Analysts Offer Insights on NA Companies: Cerebras Systems, Inc. Class A (CBRS), CitroTech (CITR) and First Tracks Biotherapeutics Inc (TRAX)
- A Quick Look at Today's Ratings for First Tracks Biotherapeutics(TRAX.US), With a Forecast Between $57 to $95
- Analysts Offer Insights on NA Companies: First Tracks Biotherapeutics Inc (TRAX), BETA Technologies, Inc. Class A (BETA) and Cerebras Systems, Inc. Class A (CBRS)
- UBS Initiates First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Announces Target Price $65
- Wedbush Maintains First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Raises Target Price to $60 正面
暂无评论——快来第一个聊聊 TRAX。